← All organizations

Research Institute of Fundamental and Clinical Immunology

Academic/Hospital

Also known as: Research Institute of Fundamental and Clinical Immunology | RIFCI

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Sep 27, 2016

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

NCT03214939Lead sponsorEarly Phase 1Sep 27, 2016
NCT03214939Study directorEarly Phase 1Sep 27, 2016
NCT03113019Lead sponsorEarly Phase 1Feb 11, 2014

Details

Last known activity: Sep 27, 2016